Born out of the Neu Soft Tissue Bioengineering Lab at CU Boulder, TissueForm supplies natural replacement biomaterials to the next generation of implantable medical devices to positively impact patients suffering from tissue loss due to disease, damage, or aging. The biomedical technology company is focusing on the pathway to commercialize its first product, NatruDerme, looking to raise seed financing alongside non-dilutive federal and state grants to enable critical FDA-pathway defined manufacturing and pre-clinical studies.